Part B: Application Problem 11-2A a-b (Part Level Submission)
Pharma Shop Ltd. is a mid-sized public company that had been in operation for many years. On December 31, 2019, it had an unlimited number of common shares authorized and 6,300,000 shares issued at an average value of $25 per share. As well, there were 6,100,000 preferred shares authorized, with 305,000 of them issued at $18 per share. The balance in retained earnings was $26,710,000. The balance in accumulated other comprehensive income was $540,000. The preferred shares pay an annual dividend of $2 per share. During 2020, the following transactions affected shareholders equity:
Application Problem 11-2A a-b (Part Level Submission) Pharma Shop Ltd. is a mid-sized public company that had been in operation for many years. On December 31, 2019, it had an unlimited number of common shares authorized and 6,300,000 shares issued at an average value of $25 per share. As well, there were 6,100,000 preferred shares authorized, with 305,000 of them issued at $18 per share. The balance in retained earnings was $26,710,000. The balance in accumulated other comprehensive income was $540,000. The preferred shares pay an annual dividend of 52 per share. During 2020, the following transactions affected shareholders' equity: 1. In total, 160,000 new common shares were issued at $30 per share. 2. The preferred dividend for the year was declared and paid. 3. A 10% common stock dividend was declared when the market price was $33 per share. The shares were distributed one month after the declaration. 4. In early December 2020, a dividend of $1.50 per share was declared on the common shares. The date of record was December 15, 2020. The dividend will be paid the following year. 5. The company earned a net income of $14,950,000 and had an ather comprehensive loss of $145,000. 6. On December 31, 2020, the company declared a two-for-one stock split on common shares. Your answer is correct. Use a spreadsheet or table format like the one in the first practice problem to track all of the changes in the shareholders' equity accounts in 2020. (If an amount reduces the account balance then enter with negative sign, e.g. -15,000 or in parenthesis, e.g. (15,000).) Number of common shares Preferred shares 15490000 Date Accumulated other comprehensive income Retained Earnings 12671000 Dec. 31, 2019 6300000 Total 1902400 540000 1. issued common shares 160000 Number of preferred Common Shares Shares 1575000 30000 T800000 1 1 1 2131800 1800000 2. preferred share dividends |-610000 3. 10% stock dividend on common shares 0 4. common share dividend -610000 -2131801 |-106590 1495000 I -1065901 5a. net income for year 1495000 5b. other comprehensive (loss) for year I -145000 -145000 -145000 6. two-for-one stock split on common shares I 7106000 1421200 Dec. 31, 2020 1836180 305000 15490000 $9073000 395000 1985760 CUOLITET OE ACCOUNTS (b) Prepare the statement of changes in shareholders' equity for 2020 and the shareholders' equity section of the statement of financial position as at the end of 2020. (Hint: The statement of changes in shareholders' equity will be similar to the table from part a' but similar transactions, such as dividends, will be grouped into one line.) (If an amount reduces the account balance then enter with negative sign, e.g. -15,000 or in parenthesis, e.g. (15, 000).) Pharma Shop Ltd. Statement of Changes in Shareholders' Equity Year Ended December 31, 2020 Number of preferred Preferred Common Shares shares Shares Number of common shares Retained Earnings Accumulated other comprehensive income Total Dec. 31, 2019 Common shares issued Cash dividends Stock dividend - common shares Net income Other comprehensive loss Stock split on common shares Dec. 31, 2020 Pharma Shop Ltd. Statement of Shareholders' Equity December 31, 2020
